Overview
Name
Fund Family
Underlying Index
Inception Date
Exchange
Description
The ARK Genomic Revolution ETF seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and U.S. exchange traded foreign equity securities of companies across multiple sectors, including health care, information technology, materials, energy and consumer discretionary, that are relevant to the Fund?s investment theme of the genomics revolution.
Investment Information
Managed Assets, $K
Shares Outstanding, K
Asset Class
Sectors
ETFs - Biotech
60-Month Beta
Net Asset Value
Management Fee
Most Recent Dividend
Last Dividend Date
Dividend Yield
Has Options
20-Day Average Volume
52-Week RangeLow price22.33-High price34.37
YTD Return %
1-Year %Chg
3-Year %Chg
5-Year %Chg